Sabine Arnolds, Klaus Rave. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Blood Glucose/drug effectsDiabetes Mellitus, Type 2/bloodDiabetes Mellitus, Type 2/drug therapyDrug SynergismGlycated Hemoglobin A/drug effectsHumansHypoglycemia/chemically inducedHypoglycemic Agents/pharmacologyHypoglycemic Agents/therapeutic useInsulin/adverse effectsInsulin/analogs & derivativesInsulin/pharmacologyInsulin/therapeutic useInsulin GlargineInsulin LisproInsulin, Long-ActingSulfonylurea Compounds/pharmacologySulfonylurea Compounds/therapeutic use
Substances： See more » Blood GlucoseGlycated Hemoglobin AHypoglycemic AgentsInsulinInsulin LisproInsulin, Long-ActingSulfonylurea CompoundsInsulin Glargineglimepiride
Year: 2008 PMID： 18675680 DOI： 10.1016/S0140-6736(08)61151-4
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321